You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB0296 HMG-COA reductase inhibitor drugs (STATINS) benefit in cardiovascular risk prevention and ameliorate disease activity in patients with rheumatoid arthritis

Alerts

Article menu

Download PDFPDF

Abstracts Accepted for Publication
Rheumatoid arthritis - comorbidity and clinical aspects
AB0296 HMG-COA reductase inhibitor drugs (STATINS) benefit in cardiovascular risk prevention and ameliorate disease activity in patients with rheumatoid arthritis
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address